The fill patient identifier is (b)(6).The customer did not supply patient demographics such as age, date of birth, sex, weight, ethnicity or race.The access sars-cov-2 igg reagent was not returned for evaluation.No hardware errors or other assay issues were reported in conjunction with this event.One patient sample was sent to the marseilles complaint handling unit for investigation.The patient sample was first tested for the sars-cov-2 igg assay.The marseilles chu obtained a reactive result (4.81 s/co).The customer's result was not confirmed.Then, the patient sample was tested with the sars-cov-2 igm assay.The sample was also reactive with the igm assay (32.22 s/co).In conclusion the result obtained by the customer was not reproduced.The patient sample was found reactive for both the access sars-cov-2 igg and access sars-cov-2 igm assays.The cause of this event cannot be determined with the information available.There is no evidence to reasonably suggest that a malfunction occurred in conjunction with this event.
|
On (b)(6) 2020, the customer reported a non-reactive sars-cov-2 igg (access sars-cov-2 igg assay, part number c58961, lot number 971197) result was generated on the customer's dxi 800 immunoassay analyzer (part number 973100 and serial number (b)(4)).The patient was coughing and have bilateral pneumonia since (b)(6) 2020.A positive pcr result was obtained on (b)(6) 2020.The patient was hospitalized on (b)(6) 2020, the pcr was positive and a non-reactive diasorin sars-cov-2 igg result was obtained.The pcr was then negative on (b)(6) 2020, but positive again on (b)(6) 2020.At this date, a reactive diasorin sars-cov-2 igg result was obtained.The patient was discharged from the hospital on (b)(6) 2020 after a negative pcr was obtained.The access sars-cov-2 igg result was non-reactive on (b)(6) 2020.Refer to relevant tests section below for more details.No affect to patients, or end-users has been reported in connection with this event.The customer did not indicate if the result was released outside the laboratory.No hardware errors or issues with other assays were reported in conjunction with this event.Calibration passed on 13nov2020.Quality control (qc) was passing within the laboratory¿s established ranges.System check passed on 9nov2020 and 16nov2020.There were no issues with sample integrity reported by the customer.Sample collection, handling and processing information such as sample type, sample volume collected, centrifugation, storage, and other sample related information was not provided by the customer.
|